oral semaglutide cardiovascular outcomes soul trial results 2024 2025 (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine Canadian Perspectives 2025 Whiteboard on

Improved glycaemic control from Wegovy may actually reduce yeast infection risk over time in patients with diabetes

Richardson is dedicated to providing personalized and effective care for her patients

For example, in the injury repair of connective tissues such as tendons and ligaments, BPC 157 can accelerate the synthesis of collagen, provide structural support for the tissues and promote healing

Exercise Exercise is one of the best treatments for menopause and joint pain

Therefore it was posited to be the result of an increase in muscle tissues and water retention

If you have other health problems like diabetes or kidney disease, the dose may have to be adjusted